Salarius Pharmaceuticals Inc. Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
High volatility in Salarius Pharmaceuticals Inc. stock price on Wednesday which ended trading at $0.536
(Updated on May 01, 2024)
The Salarius Pharmaceuticals Inc. stock price gained 7.47% on the last trading day (Wednesday, 1st May 2024), rising from $0.499 to $0.536. During the last trading day the stock fluctuated 15.11% from a day low at $0.470 to a day high of $0.541. The price has been going up and down for this period, and there has been a 5.05% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 30 thousand more shares were traded than the day before. In total, 40 thousand shares were bought and sold for approximately $21.20 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -17.14% during the next 3 months and, with a 90% probability hold a price between $0.339 and $0.498 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
SLRX Signals & Forecast
Mostly positive signals in the chart today. The Salarius Pharmaceuticals Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.503 and $0.524. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, April 02, 2024, and so far it has risen 18.60%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Salarius Pharmaceuticals Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Salarius Pharmaceuticals Inc. stock
Salarius Pharmaceuticals Inc. finds support from accumulated volume at $0.510 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.0710 (15.11%) between high and low. For the last week, the stock has had daily average volatility of 7.99%.
Our recommended stop-loss: $0.508 (-5.37%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 21 days ago.)
Trading Expectations (SLRX) For The Upcoming Trading Day Of Thursday 2nd
For the upcoming trading day on Thursday, 2nd we expect Salarius Pharmaceuticals Inc. to open at $0.516, and during the day (based on 14 day Average True Range), to move between $0.487 and $0.586, which gives a possible trading interval of +/-$0.0494 (+/-9.20%) up or down from last closing price. If Salarius Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 18.41% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.510 (4.90%) than the resistance at $0.570 (6.30%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Salarius Pharmaceuticals Inc. will release earnings BMO on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$6.70. We will update the financials statements for Salarius Pharmaceuticals Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 12.99% in the first trading day after earnings release.
Is Salarius Pharmaceuticals Inc. stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.
Current score: 3.835 Buy Candidate Upgraded
Predicted Opening Price for Salarius Pharmaceuticals Inc. of Thursday, May 2, 2024
| Fair opening price May 2, 2024 | Current price |
|---|---|
| $0.516 ( 3.83%) | $0.536 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for SLRX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.587 | 9.41 % | |
| R2 | 0.560 | 4.35 % | ||
| R1 | 0.543 | 1.23 % | ||
| Current price: | 0.536 | |||
| Support | S1 | 0.489 | -8.89 % | |
| S2 | 0.472 | -12.01 % | ||
| S3 | 0.445 | -17.07 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.659 | 22.88 % | |
| R2 | 0.580 | 8.07 % | ||
| R1 | 0.570 | 6.30 % | ||
| Current price | 0.536 | |||
| Support | S1 | 0.510 | -4.90% | |
| S2 | 0.490 | -8.63% | ||
| S3 | 0.485 | -9.57% |
FAQ
Click here for our free guide on how to buy Salarius Pharmaceuticals Inc. Stock.
